FindTrial
Sign In

Early detection of jaundice in newborn children

Hand-held mobile based device for invasive Bilirubin monitoring in neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015324
Enrollment
500
Registered
2018-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P599- Neonatal jaundice, unspecified

Interventions

None listed

Sponsors

Indian Council of Medical Research
Lead Sponsor
Sri Sathya Sai Institute of Higher Learning
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All neonates between 0 to 3 weeks of life presenting to the Sri Sathya Sai General Hospital with clinically visible jaundice will be part of this study

Exclusion criteria

Exclusion criteria: 1. Neonates who have received phototherapy, without the skin patch. 2. Where skin condition does not permit, such as Ichthyosis and Hydrops. 3. Neonates who have received exchange transfusion for any reason.

Design outcomes

Primary

MeasureTime frame
Real-time estimation of bilirubin in neonates using multi-spectral and digital image data obtained from the hand-held device.Timepoint: Blood sampling every 12 hours. In addition to this, the study will incorporate screening for bilirubin in neonates delivered at SSSGH at 72 hours of life as a part of the unitââ?¬â?¢s standard operating procedure. The hour specific Bhutani nomogram will be used to guide subsequent follow-up.—

Secondary

MeasureTime frame
Facilitate the early diagnosis and management of jaundice in neonatesTimepoint: 3 years—

Countries

India

Contacts

Public ContactDr Sai Sathish Ramamurthy

Sri Sathya Sai Institute of Higher Learning

rsaisathish@sssihl.edu.in08790314405

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026